Skip to main content

Tweets

Save the date! We are covering #EULAR24 ! Will we see you there? https://t.co/aMGYnPxlXh
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
No Link Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance Annals of Internal Medicine reports a study of more than 75,000 persons screened for MGUS and found no association between AIRD and MGUS. https://t.co/F8diWbUYPf https://t.co/M53Dgphcge
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
Australian multicenter KARAOKE RCT of 262 adults w/ Knee OA (w/ MRI effusion/synovitis) Rx w/ placebo vs , 2 g/d of krill oil showed no significant benefit in pain VAS score, −19.9 [krill oil] vs −20.2 [placebo]. https://t.co/aeNcVM0p8J https://t.co/2PR0PG6eWj
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
Upside/Downside of Steroids in Lupus Nephritis A systematic review of randomized clinical trials of patients with biopsy-proven lupus nephritis (LN) demonstrates both the benefits and harms to early glucocorticoid (GC) regimens on lupus outcomes. https://t.co/T88365IT9r https://t.co/xe5AmErLy2
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
384 Psoriasis pts followed mean 33 mos, 56 (14.6%) developed new-onset PsA. 311/384 (81%) had arthralgia (subclinical PsA) & 9.4% got PsA within 12 mos (23% by 36%). Subclinical more likely than PSO to get PsA (OR 11.7) https://t.co/9t41cjROwW https://t.co/9AelBwoRzs
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
Full read review of the benefits & impact of hydroxychloroquine in #SLE. Benefits on: - T cells, cytokines, TLR signaling - VTE prevention - Decr CV risks - Glucose & lipid benefits - Pregnancy https://t.co/bio9cYCIeb https://t.co/zfyUBaecbu
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
Brazilian Registry of Spondyloarthritis study of 1096 SpA pts, found 73% HLA-B27 positivity. B27+ signif assoc w/ males, earlier onset/Dx, uveitis, +FHx. B27 negativity assoc w/ psoriasis, higher peripheral arthritis/disease activity, worse QOL, mobility https://t.co/OUOVozdoXw https://t.co/z8hhPjRUfx
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
Small-molecule Drugs to Treat Systemic Lupus Erythematosus A metanalysis of randomized controlled trials (RCTs) on treatments of systemic lupus erythematosus (SLE), confirm the efficacy of several targeted small-molecule drugs. https://t.co/LKLUT8kLSk https://t.co/1SbUbiCpYs
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
Window of Opportunity in Psoriatic Arthritis The Dutch southwest Early psoriatic arthritis (PsA) cohort study has demonstrated that the earlier the referral and diagnosis of PsA, the better the outcome. https://t.co/eUL1wzrXVt https://t.co/XSETW2zpGs
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
Research presented at DDW 2024 demonstrated the superiority of guselkumab over ustekinumab or placebo in 1,021 patients with moderately to severely active Crohn's disease enrolled in the phase III GALAXI 2 and GALAXI 3 trials https://t.co/HdZf24Twsq https://t.co/REeAAskpX5
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
DRESS - Drug Reaction With Eosinophilia and Systemic Symptoms - review on JAMA. Common drugs include allopurinol, Bactrim, Minocin, etc. https://t.co/1DmgyX33Cl

Dr. John Cush @RheumNow ( View Tweet )

1 year 8 months ago
No Link Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance Annals of Internal Medicine reports a study of more than 75,000 persons screened for MGUS and found no association between AIRD and MGUS. https://t.co/cTuIWU7eoa https://t.co/78kQvBGVzs
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
×